TB-500 10mg
Thymosin Beta-4 Peptide for Systemic Tissue Repair and Flexibility
TB-500 (Thymosin Beta-4) is a ubiquitous actin-sequestering protein fragment studied for its profound effects on wound healing, angiogenesis, muscle repair, and flexibility — including cardiac and neurological tissue recovery that most peptides cannot reach.
Thymosin Beta-4 Peptide for Systemic Tissue Repair and Flexibility
Thymosin Beta-4 is found in virtually all human cells and plays a critical role in actin polymerization, cell migration, and angiogenesis. TB-500 is the active 4-14 fragment that retains the full healing properties while enabling systemic distribution after injection.
As one of the most studied compounds in the recovery & healing research space, TB-500 has attracted sustained scientific interest across Systemic injury recovery research, Cardiac tissue repair studies, Wound healing protocols. Peer-reviewed evidence indicates that accelerates wound healing and reduces inflammation in multiple models, which has positioned TB-500 as a reference standard for researchers exploring systemic injury recovery research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
TB-500 Documented Benefits: 5 Documented Mechanisms
Systemic Healing Distribution
Travels systemically to reach injury sites throughout the body, including heart, brain, and spinal cord.
Angiogenesis Promotion
Stimulates new blood vessel formation at injury sites, accelerating tissue oxygenation and repair.
Muscle Fiber Repair
Reduces inflammation and accelerates satellite cell-driven muscle fiber regeneration.
Cardiac Healing
Unique among peptides in showing cardiac tissue repair capability in post-MI animal models.
Flexibility Enhancement
Research subjects report improved joint flexibility alongside injury recovery.
How TB-500 Works: Molecular Mechanism & Pathway
Actin-sequestering tetrapeptide (LKKTETQ) activating angiogenesis, cell migration via Rho-kinase modulation, and anti-inflammatory COX-2 suppression for systemic tissue repair.
The 5 primary research pathways identified for TB-500 — Systemic Healing Distribution, Angiogenesis Promotion, Muscle Fiber Repair — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that cardiac repair shown in post-MI rat models, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, TB-500's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
TB-500 is routinely studied alongside BPC-157 and ARA-290 in recovery & healing-focused compound panels. Researchers investigating systemic injury recovery research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that systemic distribution distinguishes it from site-specific peptides has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All TB-500 research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Accelerates wound healing and reduces inflammation in multiple models
- Cardiac repair shown in post-MI rat models
- Systemic distribution distinguishes it from site-specific peptides
Ideal For
- Systemic injury recovery research
- Cardiac tissue repair studies
- Wound healing protocols
- Musculoskeletal recovery research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on TB-500. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Accelerates wound healing and reduces inflammation in multiple models
Cardiac repair shown in post-MI rat models
Systemic distribution distinguishes it from site-specific peptides
Third-Party Verified Every Batch
Each vial of TB-500 is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
